Although liver synthesizes IGF-1, IGF-2 and their binding proteins (IGFBPs) at a high level under the normal condition, the expression levels significantly decrease under pathogenic conditions like non-alcoholic fatty liver disease (NAFLD), cirrhosis, and HCC [88]. The gene discussed is IGF2; the disease is metabolic dysfunction-associated steatotic liver disease.